Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human ACP5 Protein, N-GST

Catalog #:   YHD00101 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P13686
Protein length: Gln79-Arg318
Overview

Catalog No.

YHD00101

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Gln79-Arg318

Predicted molecular weight

54.25 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P13686

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

ACP5, Tartrate-resistant acid ATPase, TR-AP, TrATPase, Tartrate-resistant acid phosphatase type 5, Type 5 acid phosphatase

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human ACP5 protein
References

Effect of vitamin B1 supplementation on bone turnover markers in adults: an exploratory single-arm pilot study., PMID:40371216

Norwogonin Attenuates Inflammatory Osteolysis and Collagen-Induced Arthritis via Modulating Redox Signalling and Calcium Oscillations., PMID:40099974

The regulatory role of ACP5 in the diesel exhaust particle-induced AHR inflammatory signaling pathway in a human bronchial epithelial cell line., PMID:40087344

Arcyriaflavin A Alleviates Osteoporosis by Suppressing RANKL-Induced Osteoclastogenesis., PMID:40076762

The DHH-DHHA1 domain phosphodiesterase of Mycoplasma bovis employs multiple strategies to modulate macrophage cellular processes., PMID:40023422

TRAPping the effects of tobacco smoking: the regulation and function of Acp5 expression in lung macrophages., PMID:39993028

Isonardosinone attenuates osteoclastogenesis and OVX-induced bone loss via the MAPK/NF-κB pathway., PMID:39956462

The Sirt1/FOXO signal pathway involves in regulating osteomyelitis progression via modulating mitochondrial dysfunctions and osteogenic differentiation., PMID:39939446

Molecular Profiling of Odontoclasts during Physiological Tooth Replacement., PMID:39876039

Clinical, laboratory, and molecular characteristics of patients with spondyloenchondrodysplasia: a case series study., PMID:39853520

[Effect of osteon-like concentric microgroove structures of different sizes on the osteoclastic differentiation of macrophages]., PMID:39848804

Identification of therapeutic target genes for age-related hearing loss through systematic genome-wide mendelian randomization of druggable genes., PMID:39778696

Psychological stress disturbs bone metabolism via miR-335-3p/Fos signaling in osteoclast., PMID:39773351

Stigmasterol mitigates estrogen-deficiency-induced osteoporosis through inhibition of phosphorylated p65 and MAPK signaling pathways., PMID:39741634

Development and characterization of an in vitro fluorescently tagged 3D bone-cartilage interface model., PMID:39600948

A NOTCH2 pathogenic variant and HES1 regulate osteoclastogenesis in induced pluripotent stem cells., PMID:39571704

A rare case of late-onset spondyloenchondrodysplasia with immune dysregulation presenting as adult-onset monogenic lupus., PMID:39560632

4-Hydroxyphenylacetic Acid, a microbial-derived metabolite of Polyphenols, inhibits osteoclastogenesis by inhibiting ROS production., PMID:39520963

Substrate-Mediated Regulation of Src Expression Drives Osteoclastogenesis Divergence., PMID:39336808

Trends of bone mineral density and bone quality in a paediatric kidney transplant recipient: A case report., PMID:39315463

Levels of B-ALP and TRAP-5b in a patient with short root anomaly: a case report., PMID:39275837

Candidate Biomarkers for Response to Treatment in Psoriatic Disease., PMID:39218451

Irilin D suppresses RANKL-induced osteoclastogenesis and prevents inflammation-induced bone loss by disrupting the NF-κB and MAPK signaling pathways., PMID:39209096

Cross-talk between oxidative stress and lipid metabolism regulators reveals molecular clusters and immunological characterization in polycystic ovarian syndrome., PMID:39143634

Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes bone length, regulates cortical and trabecular bone mass, and maintains growth plate architecture and width in a sex- and site-specific manner in mice., PMID:39111379

EPSTI1 promotes osteoclast differentiation and bone resorption by PKR/NF-κB signaling., PMID:39083969

Investigating the Underlying Molecular Mechanisms of Yunke on Bone Metastases from Prostate Cancer., PMID:39071978

Overexpression of the receptor for resolvin E1 (ERV1) prevents early alveolar bone loss in leptin receptor deficiency-induced diabetes., PMID:39031577

The diagnostic and prognostic value of tartrate-resistant acid phosphatase isoform 5b for giant cell tumor of bone., PMID:38995462

Ginsenoside Rb3 alleviates the formation of osteoclasts induced by periodontal ligament fibroblasts in the periodontitis microenvironment through the STAT3 pathway., PMID:38934258

14-3-3ζ suppresses RANKL signaling by destabilizing TRAF6., PMID:38908751

Development of a nanoparticle-based tendon-targeting drug delivery system to pharmacologically modulate tendon healing., PMID:38896625

Inhibition of tartrate-resistant acid phosphatase 5 can prevent cardiac fibrosis after myocardial infarction., PMID:38879488

Inhibition of caspase-8 cascade restrains the osteoclastogenic fate of bone marrow cells., PMID:38833170

Ctdnep1 phosphatase is required for negative regulation of RANKL-induced osteoclast differentiation in RAW264.7 cells., PMID:38749090

Detection of genetic mutations underlying early-onset systemic lupus erythematosus., PMID:38739464

Therapeutic potential of a prominent dihydroxyflavanone pinocembrin for osteolytic bone disease: In vitro and in vivo evidence., PMID:38685969

The Expression and Secretion Profile of TRAP5 Isoforms in Gaucher Disease., PMID:38667330

Cycloastragenol prevents bone loss via inhibiting osteoclast activity in glucocorticoid-induced osteonecrosis of the femoral head: An in vivo study., PMID:38549807

Exposure to per- and polyfluoroalkyl substances and high-throughput proteomics in Hispanic youth., PMID:38537583

Association of serum sodium levels with fractures and mortality in patients undergoing maintenance hemodialysis., PMID:38512372

RNA-based bone histomorphometry: method and its application to explaining postpubertal bone gain in a G610C mouse model of osteogenesis imperfecta., PMID:38477760

Transcriptomic and proteomic study of cancer cell lines exposed to actinomycin D and nutlin-3a reveals numerous, novel candidates for p53-regulated genes., PMID:38460933

SPI1 exacerbates iron accumulation and promotes osteoclast formation through inhibiting the expression of Hepcidin., PMID:38450475

The novel cytotoxic polybisphosphonate osteodex decreases bone resorption by enhancing cell death of mature osteoclasts without affecting osteoclastogenesis of RANKL-stimulated mouse bone marrow macrophages., PMID:38427117

STING inhibition alleviates bone resorption in apical periodontitis., PMID:38411951

Zoledronic acid enhances tumor growth and metastatic spread in a mouse model of jaw osteosarcoma., PMID:38376129

Studies on the in vitro mechanism and in vivo therapeutic effect of the antimicrobial peptide ACP5 against Trichophyton mentagrophytes., PMID:38354953

Case report: Refractory Evans syndrome in two patients with spondyloenchondrodysplasia with immune dysregulation treated successfully with JAK1/JAK2 inhibition., PMID:38347954

Piperlongumine, a Piper longum-derived amide alkaloid, protects mice from ovariectomy-induced osteoporosis by inhibiting osteoclastogenesis via suppression of p38 and JNK signaling., PMID:38311970

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human ACP5 Protein, N-GST [YHD00101]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only